[BIC-announce] FW: Seminar in Cognitive Neuroscience - Thurs., 12 Feb

Jennifer Chew, Ms. jennifer.chew at mcgill.ca
Tue Feb 10 13:39:01 EST 2009


PLEASE DISCARD IF THIS IS A DUPLICATE.  THANK YOU.  JENNIFER 
 

 

 

Reminder:  All are welcome 

 

 


Yuri Danilov, Ph.D <http://kaz.med.wisc.edu/people_senior.phpl> 


Senior Scientist


Centre for Neuroscience <http://www.neuroscience.wisc.edu/danilov.html> 


University of Wisconsin-Madison


USA


 

Cranial-nerve non-invasive neuro-modulation technology:

A new approach to neuro-rehabilitation

 


Thursday, February 12th, 2009


W201 <http://neuromedia.mcgill.ca/neuroav/killam.htm> 


3801 University Street


1:30 p.m. 


<http://www.bic.mni.mcgill.ca/users/ptito/> 

Host: Alain Ptito <http://www.bic.mni.mcgill.ca/users/ptito/> 


 

 

 

Abstract: 

 

The TCN laboratory (UW-Madison, Orthopedic and Rehabilitation Medicine
Department) developed Cranial-Nerve Non-Invasive NeuroModulation
(CN-NINM) therapy to improve and facilitate the brain's ability to
reorganize and "normalize" its affected functional activity and improve
multiple physical, cognitive and behavioral difficulties. 

 

CN-NINM uses patterns of electrical stimulation on the skin of the
tongue, face, neck and/or head. This stimulation excites neural impulses
to the brainstem and cerebellum via the lingual branch of the trigeminal
nerve and chorda tympani (branch of facial nerve). We hypothesize that
the CN-NINM causes radiating therapeutic neurochemical and
neurophysiologic changes in the brain. Functional magnetic resonance
imaging (fMRI) showed significant long lasting changes in circuitries of
the inferior cerebellum, dorsal pons varolli and medulla (all areas
deeply involved in the static and dynamic movement control processing)
after CN-NINM treatment. 

 

The result is essentially brain plasticity on demand - priming or
up-regulating of targeted neural structures to develop new functional
pathways, which is the goal of neuro-rehabilitation and a primary means
of functional recovery from brain damage. The condensed list of improved
symptoms, observed in our preliminary research on a wide range of
neurological disorders includes: improvement of static and dynamic
balance, gait, sensitivity and mobility of the paretic side, speech,
vision, recovery of sleep pattern, decrease of tinnitus and headache,
improvement of memory, attention and general well-being.

 

The CN-NINM can be considered as multi-targeted non-invasive therapy,
initiates a recovery of multiple damaged or suppressed brain functions
widely affected in traumatic brain injury patients, and might be
considered as primary and/or supplemental rehabilitation therapy.

 

 

 




More information about the BIC-announce mailing list